TCM
ETNB

TCG Crossover Management’s 89bio ETNB Stock Holding History

TCG Crossover Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,133,196
Closed -$3.65M – 23
2022
Q2 		$3.65M Buy
+1,133,196
New +$3.42M 1.55% 17

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

TCG Crossover Management's ETNB Position: Q3 2022 in Review

TCG Crossover Management sold out of 89bio (ETNB) in Q3 2022, closing a stake of 1,133,196 shares — an estimated $3.65M sold.

TCG Crossover Management first reported a position in ETNB in Q2 2022 and held it in 1 quarter. The position peaked at $3.65M in Q2 2022. 86 funds tracked by Wall St. Rank hold ETNB as of Q3 2022.

  • TCG Crossover Management reported no remaining 89bio position as of Q3 2022 after selling out during the quarter.
  • TCG Crossover Management sold 1,133,196 89bio shares in Q3 2022, an estimated $3.65M.
  • TCG Crossover Management first reported a position in 89bio in Q2 2022 and held it in 1 quarter.
  • TCG Crossover Management's 89bio position peaked at $3.65M in Q2 2022.
  • 86 funds tracked by Wall St. Rank held 89bio as of Q3 2022.

Based on TCG Crossover Management's 13F filing for Q3 2022, filed 14 Nov 2022.